| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2106101 | Blood Reviews | 2015 | 17 Pages |
Abstract
This review summarises the progress in the treatment of patients with newly diagnosed multiple myeloma, addressing critical questions such as the optimal induction, early versus late ASCT, consolidation and/or maintenance for young patients, and how we can choose the best option for non-transplant-eligible patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
MarÃa-Victoria Mateos, Enrique M. Ocio, Bruno Paiva, Laura Rosiñol, JoaquÃn MartÃnez-López, Joan Bladé, Juan-José Lahuerta, Ramón GarcÃa-Sanz, Jesús F. San Miguel,